Liraglutide is a first-generation GLP-1 receptor agonist. Saxenda (3mg/day) is FDA-approved for weight loss with SCALE trial results showing ~8% average weight loss. Victoza is used for type 2 diabetes. Being a daily injection, it is being superseded by weekly options. Compare all GLP-1s | Start assessment. Sources: FDA, NIH